scholarly journals 1970. Phase 1 Clinical Trial of Intranasal Immunization with M2-Deficient, Single Replication, Live Influenza Vaccine (M2SR): Safety and Immune Response in Adults

2018 ◽  
Vol 5 (suppl_1) ◽  
pp. S571-S572
Author(s):  
Joseph Eiden ◽  
Gilad Gordon ◽  
Carlos Fierro ◽  
Robert Belshe ◽  
Harry Greenberg ◽  
...  
Vaccine ◽  
2012 ◽  
Vol 30 (11) ◽  
pp. 1951-1958 ◽  
Author(s):  
Ellen F. Boudreau ◽  
Matthew Josleyn ◽  
Diane Ullman ◽  
Diana Fisher ◽  
Lonnie Dalrymple ◽  
...  

PLoS ONE ◽  
2018 ◽  
Vol 13 (11) ◽  
pp. e0206837 ◽  
Author(s):  
Katherine V. Houser ◽  
Galina V. Yamshchikov ◽  
Abbie R. Bellamy ◽  
Jeanine May ◽  
Mary E. Enama ◽  
...  

Blood ◽  
2014 ◽  
Vol 123 (15) ◽  
pp. 2308-2316 ◽  
Author(s):  
David H. McDermott ◽  
Qian Liu ◽  
Daniel Velez ◽  
Lizbeeth Lopez ◽  
Sandra Anaya-O’Brien ◽  
...  

Key Points Plerixafor can be given safely to WHIM syndrome patients twice daily for a 6-month period and appears promising as a treatment.


Sign in / Sign up

Export Citation Format

Share Document